Clinical trial

Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido

NCT00131495 · Warner Chilcott, Industry · Completed

Key facts

NCT number NCT00131495
Title Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido
Official title A Randomized, Double-Blind, Placebo-controlled, Parallel-group, 52-week Study to Evaluate the Efficacy/Safety of Transdermal Patches Delivering Testosterone in Menopausal Women With Low Libido Not Receiving Estrogen Therapy
Lead sponsor Warner Chilcott, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Hypoactive Sexual Desire Disorder
Intervention type Drug
Interventions Testosterone (transdermal patches), Placebo patch
Enrollment 814
Start date Jul 1, 2004
Primary completion Feb 1, 2006
Completion Feb 1, 2007
First posted Aug 18, 2005
Last update posted Apr 17, 2013
Countries Australia

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies